Antibiotics


  • FDA Grants QIDP Designation to Two Cubist Phase 3 Antibiotic Candidates
    Cubist Pharmaceuticals, Inc. announces that the Food and Drug Administration (FDA) has designated two of the company’s Phase 3 antibiotic candidates, CXA-201 (ceftolozane/tazobactam) and CB-315, as Qualified Infectious Disease Products (QIDP). The QIDP designations will ...More
    December 10, 2012
    Posted in News
  • BioMAP Screening Procedure Could Streamline Search for New Antibiotics
    Researchers at the University of California, Santa Cruz, have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical extracts from natural sources. Public health officials warn of a looming ...More
    November 26, 2012
    Posted in News
  • When Antibiotics Lead to Deadly Diarrhea
    It’s day five of Get Smart About Antibiotics Week. In today’s CDC Safe Healthcare Blog, Matthew Wayne MD, CMD, of the American Medical Directors Association (AMDA) takes a close look at Clostridium difficile, a major cause of acute, antibiotic-associated diarrhea in the ...More
    November 16, 2012
    Posted in News
  • Second Most Common Infection in the U.S. is Harder to Treat With Current Antibiotics
    Certain types of bacteria responsible for causing urinary tract infections (UTIs), the second-most-common infection in the United States, are becoming more difficult to treat with current antibiotics, according to new research from Extending the Cure (ETC), a project of the ...More
    November 13, 2012
    Posted in News
  • Researchers "Watch" Antibiotics Attack Tuberculosis Bacteria Inside Cells
    Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes. As a ...More
    November 2, 2012
    Posted in News
  • Antibiotics That Only Partly Block Protein Machinery Allow Germs to Poison Themselves
    Powerful antibiotics that scientists and physicians thought stop the growth of harmful bacteria by completely blocking their ability to make proteins actually allow the germs to continue producing certain proteins -- which may help do them in. The finding, by a team at the ...More
    October 26, 2012
    Posted in News
  • Additive Restores Antibiotic Effectiveness Against MRSA
    Researchers from North Carolina State University have increased the potency of a compound that reactivates antibiotics against methicillin-resistant Staphylococcus aureus (MRSA), an antibiotic-resistant form of Staphylococcus that is notoriously difficult to treat. Their ...More
    October 22, 2012
    Posted in News
  • Cholera Discovery Could Revolutionize Antibiotic Delivery
    Three Simon Fraser University scientists are among six researchers who’ve made a discovery that could help revolutionize antibiotic treatment of deadly bacteria. Lisa Craig, Christopher Ford and Subramaniapillai Kolappan, SFU researchers in molecular biology and ...More
    October 22, 2012
    Posted in News
  • Antibiotics Not Effective for Cough Due to Common Cold in Children
    New research suggests that antibiotics are not effective in treating cough due to the common cold in children. The study, presented at CHEST 2012, the annual meeting of the American College of Chest Physicians, found that when children with acute cough were treated with ...More
    October 22, 2012
    Posted in News
  • Antibiotic Shows Promise in Treating Extensively Drug-Resistant Tuberculosis
    When tested in patients hospitalized with extensively drug-resistant tuberculosis (XDR-TB) unresponsive to previous treatment, linezolid, an antibiotic used to treat severe bacterial infections, proved largely effective when added to the patients' ongoing TB treatment ...More
    October 18, 2012
    Posted in News